These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21277122)

  • 1. The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: preliminary results.
    Lanari M; Adorni F; Silvestri M; Coscia A; Musicco M;
    Early Hum Dev; 2011 Mar; 87 Suppl 1():S43-6. PubMed ID: 21277122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are late preterm infants as susceptible to RSV infection as full term infants?
    Resch B; Paes B
    Early Hum Dev; 2011 Mar; 87 Suppl 1():S47-9. PubMed ID: 21276672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children.
    Madhi SA; Kuwanda L; Cutland C; Klugman KP
    J Clin Virol; 2006 Jul; 36(3):215-21. PubMed ID: 16678480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
    Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
    Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.
    Stevens TP; Sinkin RA; Hall CB; Maniscalco WM; McConnochie KM
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):55-61. PubMed ID: 10632251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks' gestational age.
    Doering G; Gusenleitner W; Belohradsky BH; Burdach S; Resch B; Liese JG
    Pediatr Infect Dis J; 2006 Dec; 25(12):1188-90. PubMed ID: 17133170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy.
    Medici MC; Arcangeletti MC; Merolla R; Chezzi C;
    Acta Biomed; 2004 Apr; 75(1):26-33. PubMed ID: 15315084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
    Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
    Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus risk factors in late preterm infants.
    Lanari M; Silvestri M; Rossi GA
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():102-7. PubMed ID: 19925369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
    Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention.
    Stewart DL; Romero JR; Buysman EK; Fernandes AW; Mahadevia PJ
    Curr Med Res Opin; 2009 Nov; 25(11):2795-804. PubMed ID: 19788406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants.
    Broughton S; Roberts A; Fox G; Pollina E; Zuckerman M; Chaudhry S; Greenough A
    Thorax; 2005 Dec; 60(12):1039-44. PubMed ID: 16227330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late preterm infants and risk for RSV.
    Coffman S
    MCN Am J Matern Child Nurs; 2009; 34(6):378-84; quiz 385-6. PubMed ID: 19901700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life.
    Escobar GJ; Ragins A; Li SX; Prager L; Masaquel AS; Kipnis P
    Arch Pediatr Adolesc Med; 2010 Oct; 164(10):915-22. PubMed ID: 20921348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data.
    Simões EA; Carbonell-Estrany X; Fullarton JR; Rossi GA; Barberi I; Lanari M;
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):152-7. PubMed ID: 20486882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient RSV lower respiratory infections among high-risk infants and other pediatric populations.
    Paramore LC; Mahadevia PJ; Piedra PA
    Pediatr Pulmonol; 2010 Jun; 45(6):578-84. PubMed ID: 20503283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.